Stock comparison
Privia Health Group
PRVA
Market cap
$2.73B
Sector
Healthcare
Overall winner
Thermo Fisher Scientific
PRVA 2–5 TMO
Thermo Fisher Scientific
TMO
Market cap
$175.7B
Sector
Healthcare
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
PRVAvsTMO
25F
52C
32F
74B
49D
40D
44D
28F
2F
51D
29F
52D
34F
45D
Side-by-side metrics
| Metric | PRVA | TMO |
|---|---|---|
| Market cap | $2.73B | $175.7B |
| P/E (TTM) | 129.8x | 26.4x |
| EV/EBIT | - | 27.2x |
| ROIC (TTM) | 0.0% | 7.33% |
| Gross margin | 9.59% | 39.41% |
| Net margin | 0.97% | 15.18% |
| Revenue CAGR 5y | 21.75% | 3.25% |
| EPS CAGR 5y | - | -2.43% |
| Debt / Equity | 0.0x | 0.8x |
| Dividend yield | 0.0% | 0.36% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
PRVA leads on
- EV/EBIT-vs 27.2x+100%
- Debt / Equity0.0xvs 0.8x+99%
- Revenue CAGR 5y21.75%vs 3.25%+85%
TMO leads on
- Dividend yield0.36%vs 0.0%+100%
- ROIC (TTM)7.33%vs 0.0%+100%
- Market cap$175.7Bvs $2.73B+98%
- Net margin15.18%vs 0.97%+94%
More like PRVA
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.